Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Cerulean Pharma (CERU) Presents at Rodman & Renshaw Conference

Cerulean Pharma, Inc. (NASDAQ: CERU) is focused on making nanoparticle-drug conjugates (NDCs) designed to target rumors, reduce toxicity and enable combinations. The Cerulean team is committed to developing products to improve treatment options for people living with cancer. The company applies its Dynamic Tumor Targeting Platform to create a growing portfolio of NDCs designed to selectively attack tumor cells, reduce toxicity by sparing the body’s normal cells, and enable therapeutic combinations. For more information, visit the company’s website at

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. For more information on Rodman & Renshaw, visit
This entry was posted in Rodman and Renshaw Conference. Bookmark the permalink.

Comments are closed.